Home/Pipeline/Biosimilars Program

Biosimilars Program

Immunology, Oncology

Development & CommercialActive (Partnership-led)

Key Facts

Indication
Immunology, Oncology
Phase
Development & Commercial
Status
Active (Partnership-led)
Company

About Aspen Pharmacare

Aspen Pharmacare's mission is to improve patient health globally through high-quality, affordable medicines. The company has achieved its position as a multinational leader through a disciplined strategy of strategic acquisitions, geographic expansion into over 115 countries, and vertical integration across manufacturing and commercial operations. Its core strategy focuses on marketing and manufacturing a broad portfolio of post-patent, branded pharmaceuticals and sterile injectables, leveraging a world-class, regulatory-approved manufacturing footprint to serve both developed and emerging markets.

View full company profile

Other Immunology, Oncology Drugs

DrugCompanyPhase
Biosimilar CandidatesTowa PharmaceuticalPreclinical / Early Development
Biosimilars PipelineJubilant PharmovaEarly Development
Biosimilars DevelopmentSPIMACOExploratory / Early Development
Biosimilar PortfolioLaboratorios Farmaceuticos RoviClinical Development